|
⚲
|
| Keyboard |
| Hawryluk P Kent
✚
|
|
|---|---|
| CIK # | 0001673991 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001673991] | |
| 4 | [0001673991] | |
| SC 13G | [0001673991] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Hawryluk P Kent | MBX Biosciences Inc | [2024-11-01] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hawryluk P Kent | |
| MBX Biosciences Inc | |
| MetaVia Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
MBX Biosciences Inc MBX
Common Stock
|
2026-03-13 | Buy | 18,500 | $28.41 | 525,585 |
|
MBX Biosciences Inc MBX
Common Stock
|
2026-02-26 | Option exercise | 28,768 | $16.00 | 460,288 |
|
MBX Biosciences Inc MBX
Stock option (right to buy) · derivative
|
2026-02-26 | Option exercise | 28,768 | $0.00 | |
|
MBX Biosciences Inc MBX
Common Stock
|
2026-02-02 | Grant | 35,250 | $0.00 | |
|
MBX Biosciences Inc MBX
Stock option (right to buy) · derivative
|
2026-02-02 | Grant | 164,500 | $0.00 | |
|
MBX Biosciences Inc MBX
Stock option (right to buy) · derivative
|
2025-10-24 | Option exercise | 182,859 | $0.00 | |
|
MBX Biosciences Inc MBX
Common Stock
|
2025-10-24 | Option exercise | 182,859 | $3.25 | 594,292 |
|
MBX Biosciences Inc MBX
Common Stock
|
2025-10-20 | Buy | 20,000 | $13.64 | 272,800 |
|
MBX Biosciences Inc MBX
Common Stock
|
2025-02-04 | Buy | 50,000 | $10.69 | 534,500 |
|
MBX Biosciences Inc MBX
Stock Option (Right to Buy) · derivative
|
2025-02-03 | Grant | 243,000 | $0.00 | |
|
MBX Biosciences Inc MBX
Series A Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 2,015,681 | ||
|
MBX Biosciences Inc MBX
Common Stock
|
2024-09-16 | Conversion | 115,914 | ||
|
MBX Biosciences Inc MBX
Common Stock
|
2024-09-16 | Conversion | 283,846 | ||
|
MBX Biosciences Inc MBX
Series B Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 76,969 | ||
|
MBX Biosciences Inc MBX
Series C Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 970,873 | ||
|
MBX Biosciences Inc MBX
Series A Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 345,705 | ||
|
MBX Biosciences Inc MBX
Series B Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 1,396,762 | ||
|
MBX Biosciences Inc MBX
Stock Option (Right to Buy) · derivative
|
2024-09-12 | Grant | 120,436 | $0.00 | |
|
MetaVia Inc GEMP
Stock Option (right to buy) · derivative
|
2018-01-29 | Grant | 10,800 | $0.00 | |
|
MetaVia Inc GEMP
Warrant to Purchase Common Stock · derivative
|
2017-03-10 | Buy | 18,750 | $9.47 | 177,562 |
| showing 20 of 28 most recent transactions | |||||